Prostate Cancer

Videos

Dr Tward Discusses 2022 Anticipated Prostate Cancer Advancements Part 2

02/28/2022

In part two of this series, Dr Tward, MD, Huntsman Cancer Institute, discusses use of the Polaris test to prognosticate metastasis of men undergoing radiation therapy with prostate cancer, as well as ongoing efforts to further advance...

In part two of this series, Dr...

02/28/2022

Oncology

Videos

Dr Shen Highlights Apalutamide Therapy for Mature Patients With Advanced Prostate Cancer

09/21/2021

John Shen, MD, UCLA, discusses a combined analysis of TITAN & SPARTAN, apalutamide (APA) therapy for older patients with advanced prostate cancer, presented at the 2021 ESMO Congress.

John Shen, MD, UCLA, discusses a...

09/21/2021

Oncology

Test Your Knowledge

Quiz: Somatic Sequencing in Metastatic Prostate Cancer

07/28/2021

True or False: Somatic sequencing of metastatic tissue in prostate cancer is challenging due to the bone‑trophic nature of advanced prostate cancer, as well as the diagnostic yield from sequencing bone metastases being quite low.

True or False: Somatic...

07/28/2021

Oncology

Conference Coverage

Real-world PSA Progression After Enzalutamide or Abiraterone for Metastatic CRPC

06/24/2021

A real-world study presented at the virtual 2021 ASCO Annual Meeting evaluated prostate-specific antigen pattern progression and its association with OS among patients with metastatic CRPC who were treated with enzalutamide or abiraterone.

A real-world study presented at...

06/24/2021

Journal of Clinical Pathways

Videos

Dr Tagawa Discusses Study Results of Actinium J591 for mCRPC

06/22/2021

Scott Tagawa, MD, MS, FACP, discusses the background and findings of a phase 1 study on the use of a PSMA-targeted radionuclide therapy for patients with mCRPC.

Scott Tagawa, MD, MS, FACP,...

06/22/2021

Oncology

Conference Coverage

Physician- and Patient-Reported Outcomes Among Five Radiotherapy Methods for Prostate Cancer

06/21/2021

A recent study comparing radiotherapy methods for prostate cancer suggests that physician-reported toxicities may be lower for patients treated with high-dose-rate brachytherapy, and patient-reported outcomes may be worse for those treated...

A recent study comparing...

06/21/2021

Journal of Clinical Pathways

Interview

Dr Schweizer Talks Concordance of DDR Mutations in Paired Primary, Metastatic Prostate Cancer Samples

06/15/2021

Michael Schweizer, MD, Seattle Cancer Care Alliance, discusses a prostate cancer study that was presented at the 2021 ASCO Annual Meeting.

Michael Schweizer, MD, Seattle...

06/15/2021

Oncology

Videos

Dr Agarwal Discusses Final Analysis Results of the TITAN Study - Part 2

06/15/2021

In part two of this video series, Neeraj Agarwal, MD, shares final analysis results from the TITAN clinical trial being presented at the virtual 2021 ASCO Annual Meeting.

In part two of this video...

06/15/2021

Oncology

Videos

Dr Agarwal Discusses Final Analysis Results of the TITAN Study - Part 1

06/15/2021

In part one of this video series, Neeraj Agarwal, MD, discusses HRQoL and patient-reported outcomes at final analysis of the TITAN study being presented at the virtual 2021 ASCO Annual Meeting.

In part one of this video...

06/15/2021

Oncology

Conference Coverage

Real-World Treatment Patterns for Metastatic Castration-Sensitive Prostate Cancer

06/14/2021

More than half of patients with metastatic castration-sensitive prostate cancer did not receive first-line treatment regimens associated with improved survival compared with ADT alone in the community practice setting.

More than half of patients with...

06/14/2021

Journal of Clinical Pathways